Press Release – Greenlab Greenlab (Green Relief NZ Ltd trading as Greenlab) based at Lincoln University is positioning New Zealand at the forefront of research-driven pharmaceutical-quality cannabis cultivation and derivative products, is pleased to announce that its subsidiary, …
Greenlab (Green Relief NZ Ltd trading as Greenlab) based at Lincoln University is positioning New Zealand at the forefront of research-driven pharmaceutical-quality cannabis cultivation and derivative products, is pleased to announce that its subsidiary, Greenlab Australia Pty Ltd, has entered into an agreement to supply pharmaceutical-grade, cannabinoid pharmaceuticals to Cannvalate Pty Ltd, one of Australia’s largest distributors.
Under the two-year agreement, Greenlab will supply a range of certified cannabis products that meet the high-quality standards set by the Australian Therapeutic Goods Administration (TGA) and meeting internationally recognized GMP requirements. Greenlab and Cannvalate
Thursday, 4 February 2021, 6:47 am
Greenlab (Green Relief NZ Ltd trading as Greenlab) based
at Lincoln University is positioning New Zealand at the
forefront of research-driven pharmaceutical-quality cannabis
cultivation and derivative products, is pleased to announce
that its subsidiary, Greenlab Australia Pty Ltd, has entered
into an agreement to supply pharmaceutical-grade,
cannabinoid pharmaceuticals to Cannvalate Pty Ltd, one of
Australia’s largest distributors.
Under the two-year
agreement, Greenlab will supply a range of certified
cannabis products that meet the high-quality standards set
by the Australian Therapeutic Goods Administration (TGA) and
meeting internationally recognized GMP requirements.
Greenlab and Cannvalate will non-exclusively distribute the